Your browser doesn't support javascript.
loading
Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation.
Díaz-García, Elena; García-Tovar, Sara; Alfaro, Enrique; Zamarrón, Ester; Mangas, Alberto; Galera, Raúl; Ruíz-Hernández, José Juan; Solé-Violán, Jordi; Rodríguez-Gallego, Carlos; Van-Den-Rym, Ana; Pérez-de-Diego, Rebeca; Nanwani-Nanwani, Kapil; López-Collazo, Eduardo; García-Rio, Francisco; Cubillos-Zapata, Carolina.
Afiliação
  • Díaz-García E; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, Instituto de Investigación Biomédica del Hospital Universitario la Paz (IdiPAZ), Madrid, Spain.
  • García-Tovar S; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
  • Alfaro E; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, Instituto de Investigación Biomédica del Hospital Universitario la Paz (IdiPAZ), Madrid, Spain.
  • Zamarrón E; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, Instituto de Investigación Biomédica del Hospital Universitario la Paz (IdiPAZ), Madrid, Spain.
  • Mangas A; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, Instituto de Investigación Biomédica del Hospital Universitario la Paz (IdiPAZ), Madrid, Spain.
  • Galera R; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
  • Ruíz-Hernández JJ; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, Instituto de Investigación Biomédica del Hospital Universitario la Paz (IdiPAZ), Madrid, Spain.
  • Solé-Violán J; Respiratory Diseases Group, Respiratory Service, La Paz University Hospital, Instituto de Investigación Biomédica del Hospital Universitario la Paz (IdiPAZ), Madrid, Spain.
  • Rodríguez-Gallego C; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
  • Van-Den-Rym A; Department of Internal Medicine, Gran Canaria Dr Negrín University Hospital, Gran Canaria, Spain.
  • Pérez-de-Diego R; Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.
  • Nanwani-Nanwani K; Intensitive Care Medicine, Gran Canaria Dr Negrín University Hospital, Gran Canaria, Spain.
  • López-Collazo E; Departament of Immunology, Gran Canaria Dr Negrín University Hospital, Gran Canaria, Spain.
  • García-Rio F; Department of Clinical Sciences, University Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain.
  • Cubillos-Zapata C; Laboratory of Immunogenetics of Human Diseases, La Paz University Hospital, Instituto de Investigación Biomédica del Hospital Universitario la Paz (IdiPAZ), Madrid, Spain.
Front Immunol ; 13: 847894, 2022.
Article em En | MEDLINE | ID: mdl-35173744
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apirase / Receptores Purinérgicos P2Y / COVID-19 / Tromboinflamação Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Apirase / Receptores Purinérgicos P2Y / COVID-19 / Tromboinflamação Idioma: En Ano de publicação: 2022 Tipo de documento: Article